All Updates

All Updates

icon
Filter
Partnerships
Origin Materials partners with Avantium
Bio-based Materials
Feb 21, 2023
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Partnerships
Funding
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Bio-based Materials

Bio-based Materials

Feb 21, 2023

Origin Materials partners with Avantium

Partnerships

  • Origin Materials, a carbon-negative product manufacturer, has partnered with Avantium, a leading technology company specializing in advanced R&D for applications in the energy, chemical, and pharmaceutical industries, to accelerate the mass production of Furan dicarboxylic acid (FDCA) and Polyethylene Furanoate (PEF) for use in advanced chemicals and plastics.

  • The partnership aims to combine Origin's carbon-negative technology platform—which transforms carbon in sustainable wood residues into materials like chloromethyl furfural (CMF)—with Avantium's YXY Technology to convert derivatives of Origin's CMF into FDCA, the polymer PEF's building component.

  • The produced PEF is expected to be 100% plant-based, fully recyclable, will have favorable unit economics, and will offer a significantly reduced carbon footprint with superior strength and thermal and barrier properties.

  • Origin would receive access to relevant parts of Avantium's process technology to produce FDCA at a 100 metric kilotons per annum scale facility. Further, under the terms of the transaction, Avantium received an upfront payment of EUR 5 million in 2022 and an additional payment of EUR 7.5 million for signing the licensing agreement; it may additionally receive further payments based on the achievement of certain developmental milestones.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.